Category Archives: Biotechnology

“Marc Beer Completes Renovia’s Series B Funding “

A mention of Renovia goes hand-in-hand with the mention of Marc Beer. Who is Merc Beer? If you are coming across the name Merc Beer for the first time, it is essential to know that he is the co-founder and the current Chief Executive Officer (CEO) of a healthcare startup known as Renovia.

 

Marc Beer is a recognized and renowned American serial entrepreneur and has participated in the formation of numerous healthcare startups such as; ViaCell (established in the year200), LumeNXT (established in2018) among other health startups. Find more information on Marc Beer here; https://www.linkedin.com/in/marcbeer.

 

Renovia was founded in 2016 and has been in operation for two years. The firm has its headquarters in Boston, United States. Since its inception, Renovia’s primary objective has been to battle pelvic floor disorder, a condition that has been affecting millions of women worldwide. Women suffering from pelvic floor disorder cannot control the pelvic floor muscle; this results in the uncontrolled release of bowels.

 

In the short span, Renovia has been in operation; the startup has been able to accomplish major milestones in the treating of the pelvic store disorder. Recently, Renovia designed and released the Leva device for use in treating pelvic floor disorder. The Leva device has already received the approval of the FDA. Marc Beer has recently completed a Series B funding for the healthcare startup Renovia.

 

The Series B funding raised by Renovia will be primarily used in the development of new products. Some of the other uses of the series B funding will include commercial campaign launches and corporate development. Renovia’s Series B funding amounted to $42 million. $10 million of the $42 million was raised in venture debt.

 

Renovia’s three long-term partners played a significant role in the Series B funding. The partners that made the Series B funding a success include Ascension Ventures, Perceptive Advisors and Longwood Funds. It is worth noting that Longwood Funds also took part in Renovia’s Series A funding.

 

While commenting on the funding received by Renovia Inc. Marc Beer was quick to note the delight of the firm’s stakeholders. Marc also acknowledged the crucial role played by Perceptive Advisors, Longwood Funds, and Ascension Ventures. Marc Beer commended these three firms for sharing in Renovia’s vision of providing the best possible treatment, care, and diagnosis of patients suffering from pelvic floor disorders.

 

Other than playing a significant role in Renovia’s Series B funding, the three firms provided propriety sensor technologies. The provision of these technologies will go a long way in ensuring the condition becomes manageable to patients. Marc Beer also highlighted Renovia’s commitment to providing more information about pelvic floor disorder to both patients and the public in an attempt to increase awareness while providing a better understanding of the condition. Learn more: https://renoviainc.com/leadership/

 

Leave a Comment

Filed under Biotechnology, Entrepreneur, Finance, People

“MARC BEER RAISING $42M FOR BOSTON WOMEN’S HEALTH “

Marc Beer, through Renovia Inc., a startup he co-founded, has just made a significant contribution to the improvement of the health of women in Boston. Beer, who also founded the ViaCell, Inc. and served as its chief for seven years, has through this step demonstrated leadership. This act shows that he has not been consumed into the deep chambers of his career; the profits and loses; that he cares for the wellbeing of other people. This is not a common feat with many people who have held senior managerial positions in numerous companies. In a statement expressing his delight at being joined by the Longwood Fund for this work, Beer indeed acknowledged that he has a vision ‘to better diagnose, treat and improve the lives of millions of women affected by pelvic floor disorders’ around the world.

This donation will come in two packages; $32m for new equipment and the rest ($10m) in venture debt. Marc Beer’s contribution is set to be used for the development of material used for diagnosis and therapy to fight pelvic floor disorders which are estimated by medical researchers to affect about 250 million women in the world.

Beer, who has a lot of experience at sales and marketing management, has also excelled in research and development program management in therapeutic, surgical and in vitro diagnostic systems businesses. He has also served as a private consultant in the field of medical industry. After graduating with a Bachelors of Science in Business Administration from Miami University in Ohio, Beer grew career-wise to hold many top positions in companies doing business in the medical field. He has been a director at CytoPherx, Seaside Therapeutics LLC, Erytech Pharma Société Anonyme and Viacell companies the latest at which he also held the position of chairman. He has also served in the managerial boards, notably the Scientific and Medical Advisory Board at TxCell Promises, the Mass Life Science Board of the Commonwealth of Massachusetts as well as the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Body.

In taking this bold step, Beer has demonstrated that successful individuals need to use their expertise in not only building their companies and countries but also in giving back to society. Learn more: https://www.slideshare.net/MarcBeer

 

Leave a Comment

Filed under Biotechnology, Entrepreneur, Finance, People